101 Therapeutics Israeli Company
101 Therapeutics has developed the first-ever targeted glucocorticoid with all of the potency of steroids and none of the systemic toxicities. By targeting the host immune system rather than the pathogen itself, the company can effectively treat a multitude of infectious diseases, whether viral, parasitic, or bacterial.
Health Tech & Life Sciences
Biopharma
Biotechnology
Life Science
Medical
Pharmaceutical
Therapeutics
Alternatives
No alternatives listed yet.
Suggest an Alternative
Founders
Parent Companies/Investors
Office Locations
Tel Aviv, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/101-therapeutics
[2]
crunchbase.com
- https://www.crunchbase.com/organization/101-therapeutics
External links are provided for reference and verification purposes.